Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
✍ Scribed by Ferenc Martenyi; Nikolay N. Zavadenko; Natalia B. Jarkova; Alexandr A. Yarosh; Victoria O. Soldatenkova; Leonid M. Bardenstein; Irina A. Kozlova; Nikolay G. Neznanov; Olga I. Maslova; Andrey S. Petrukhin; Nina K. Sukchotina; Valeriy P. Zykov
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 245 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1018-8827
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Objective The aim of the present study was to further evaluate, under double blind and controlled conditions, the efficacy of amantadine for attention‐deficit/hyperactivity disorder (ADHD) in children and adolescents as compared to methylphenidate. Methods This was a 6‐week randomized
## Abstract ## Objective The main aim of this study is to evaluate the efficacy of reboxetine, a specific noradrenergic reuptake inhibitor, in adults with attention‐deficit/hyperactivity disorder (ADHD). ## Methods In a double blind placebo‐controlled clinical trial, the efficacy of 8 mg/day of
## Abstract ## Objective The present report aimed to investigate the efficacy and tolerability of venlafaxine compared to methylphenidate in children and adolescents with Attention Deficit/Hyperactivity Disorder (ADHD). ## Methods This was a 6‐week, parallel group, randomized clinical trial. Thi